Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Four-cycle TPF neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for stage IVB nasopharyngeal carcinoma
ChiCTR-OPN-16007739Phase 4Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jan 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of docetaxel, cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: Progression-free survival rate. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-OPN-16007739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16007739.